Bellosta S, Corsini A. Statin drug interactions and related adverse reactions. Expert Opin Drug Saf. 2012;11:933 46. S4.1-24. Gnjidic D, Le Couteur DG, Blyth FM, et al. Statin use and clinical outcomes in older men: a prospective population-based study. BMJ Open 2013;3:e002333. S4.1-25. Gray SL, Boudreau RM, Newman AB, et al. Angiotensin-converting enzyme inhibitor and statin use and incident mobility limitation in community-dwelling older adults: the Health, Aging and Body Composition study. J Am Geriatr Soc. 2011;59:2226 32. S4.1-26. Ho CK, Walker SW. Statins and their interactions with other lipid- modifying medications: safety issues in the elderly. Ther Adv Drug Saf. 2012;3:35 46. S4.1-27. LaCroix AZ, Gray SL, Aragaki A, et al. Statin use and incident frailty in women aged 65 years or older: prospective findings from the Women s Health Initiative Observational Study. J Gerontol A Biol Sci Med Sci. 2008;63:369 75. S4.1-28. Pilotto A, Panza F, Copetti M, et al. Statin treatment and mortality in community-dwelling S4.1-frail older patients with diabetes mellitus: a retrospective observational study. PLoS One 2015:10;e0130946. S4.1-29. Qi K, Reeve E, Hilmer SN, et al. Older people s attitudes regard- ing polypharmacy, statin use and willingness to have statins depre- scribed in Australia. Int J Clin Pharm. 2015;37:949 57. S4.1-30. Scott D, Blizzard L, Fell J, et al. Statin therapy, muscle func- tion and falls risk in community-dwelling older adults. QJM. 2009;102:625 33. S4.1-31. Thai M, Reeve E, Hilmer SN, et al. Prevalence of statin-drug interac- tions in older people: a systematic review. Eur J Clin Pharmacol. 2016;72:513 21. S4.1-32. Feldman HH, Doody RS, Kivipelto M, et al. Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe. Neurology. 2010;74:956 64. S4.1-33. Houx PJ, Shepherd J, Blauw GJ, et al. Testing cognitive function in elderly populations: the PROSPER study. 